• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Issue #3 2016 – Digital edition

30 June 2016  •  Author(s): European Pharmaceutical Review

In the digital version of Issue #3 2016:

  • European Pharmaceutical Review Issue 3 2016FOREWORD – Biosimilars: future prospects
    David P. Elder, JPAG chair and Consultant
  • REGULATORY INSIGHT: Pharma sector – long a target for antitrust enforcers
    Diarmuid Ryan and Martin Rees, Squire Patton Boggs
  • IN-DEPTH FOCUS: PACKAGING
    With articles from Martin Sawer, Healthcare Distribution Association, Maarten Van Baelen and Johan Verhaeghe, Medicines for Europe and Micael Lopes and Michael A. Graf, Deloitte Consulting
  • MICROFLUIDICS: Microfluidics in cell-to-cell signalling measurements
    Laura D. Casto and Christopher A. Baker, University of Tennessee
  • IN-DEPTH FOCUS: MICROBIOLOGY
    With articles from David Elder and Paul Newby, GlaxoSmithKline and Tim Sandle, Bio Products Laboratory. Plus a microbiology roundtable
  • PAT SERIES: Recent achievements in NIR-based on-line monitoring of lyophilisation processes
    Adrian Funke, Bayer Pharma AG, Reinhard Gross, Stephan Tosch and Albert Tulke, Bayer Technology GmbH
  • ANTIBIOTIC RESISTANCE: Interview with Bjorn Herpers, Micreos

The rest of this content is restricted to logged-in subscribers. Login or register (it's free!) to view the full content.

3 responses to “Issue #3 2016 – Digital edition”

  1. Vijayeendra Katageri says:

    Good coverage and contents of Bio similars, welcome.

  2. Tatyana says:

    I am from Russia. I work at Servier.

  3. menelaos fountas says:

    THANK U

Leave a reply

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +